Few studies consider the appropriate measurements for assessing clinical trials in children

Apr 29, 2008

Very few studies have asked what the appropriate measurements are for assessing treatments in clinical trials in children, according to a systematic review of paediatric clinical research conducted since 1950. The review by Ian Sinha and colleagues from the University of Liverpool, published in this week’s PLoS Medicine, also shows that few studies have involved parents and none have involved children in the process to select which measurements to use to assess clinical trials.

Before conducting a clinical trial of a new drug, researchers choose several “outcomes.” These are measurements chosen in advance of the trial to ensure that as much information as possible is provided about the drug’s safety, effectiveness and its impact on the patients’ health and daily life. Children’s bodies handle certain drugs very differently to adults – it can’t just be assumed that drugs effective in adults simply need to be scaled down to work for children – and so paediatric clinical trials need to be designed with these differences in mind.

By using a search strategy and consulting experts in paediatric clinical research, the researchers identified all the studies since 1950 that have examined the selection of outcomes in clinical trials conducted in children. Their initial search was very wide to minimize bias, leading to the retrieval of 9,000 abstracts. Only twenty-five articles met the criteria established by the review and examined the selection of outcomes in clinical research in children. These studies came from thirteen groups researching different conditions – including asthma, Crohn’s disease and cystic fibrosis – but for many paediatric areas there has been no work done into the selection of appropriate outcomes for clinical trials in children.

Reaching agreement on standard outcomes for clinical trials in children is important because it enables researchers and clinicians to compare and combine the results of clinical trials. Standardization also helps avoid selectivity and bias in the conduct of research. Several of the studies reviewed by Ian Sinha and colleagues used methods that had previously been used to select outcomes in clinical trials in adults. These include a technique in which individual opinions are sought and fed back into a group discussion before a final consensus agreement is reached, as well as a technique that involves face-to-face discussion followed by a vote. But although the groups selecting the appropriate outcomes in these studies included clinical experts and specialists in a particular paediatric condition, only three groups asked parents about the outcomes that should be included to assess the clinical trials and none of them asked children directly. < /span>

In an accompanying perspective, Mike Clarke of the UK Cochrane Centre and Trinity College, Dublin - not involved in the systematic review - suggests the approaches identified should “make it easier to plan, appraise and use initiatives that have already attempted to standardize outcomes.” But as Ian Sinha and colleagues conclude, further research is urgently required to make this process easier and more uniform and to involve children and their parents in assessing which outcomes should be used in clinical trials.

Citation: Sinha I, Jones L, Smyth RL, Williamson PR (2008) A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med 5(4): e96.

Source: Public Library of Science

Explore further: FTC clears Sun Pharma's $4B purchase of competitor Ranbaxy

add to favorites email to friend print save as pdf

Related Stories

Napster co-founder to invest in allergy research

Dec 17, 2014

(AP)—Napster co-founder Sean Parker missed most of his final year in high school and has ended up in the emergency room countless times because of his deadly allergy to nuts, shellfish and other foods.

Researchers grow norovirus in human cells

Nov 07, 2014

University of Florida researchers have grown a human norovirus in a cell culture dish, finally opening the door to developing medications for fighting the intestinal scourge that strikes tens of millions ...

Cloning whistle-blower: little change in S. Korea

Oct 24, 2014

The whistle-blower who exposed breakthrough cloning research as a devastating fake says South Korea is still dominated by the values that allowed science fraudster Hwang Woo-suk to become an almost untouchable ...

Recommended for you

Why aren't there any human doctors in Star Wars?

Jan 30, 2015

Though set "a long time ago in a galaxy far, far away," it isn't hard to see in the Star Wars films a vision of our own not so distant future. But Anthony Jones, a physician with a long background in health ...

Cambodia bans 'virgin surgery' adverts

Jan 29, 2015

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.